RETEAR
Live / Applied — Examiner statement mailed (as of 13 Sept 2021)
What this means for you
Not registered yet, but its 24 May 2019 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88446352
- Mark type
- Stylized text
- Filed
- 24 May 2019
- Published for opposition
- 24 Sept 2019
- Attorney of record
- Katharine Tremblay
Goods and services
- Class 005 — Pharmaceuticals: Allergy medications; Homeopathic pharmaceuticals for use in the treatment of dry eye; Medical preparations for the treatment of dry eye; Ocular pharmaceuticals; Ophthalmologic preparations; Ophthalmological preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the prevention of dry eye; Pharmaceutical preparations for the treatment and prevention of dry eye; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of dry eye; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Plant and herb extracts sold as components of medicated cosmetics; Drug delivery agents in the form of dry eye that facilitate the delivery of pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparation for skin care; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for treating allergies; Pharmaceutical products for ophthalmological use
Owner
- ReTEAR, Inc., San Diego, CA, US
- ReTEAR, Inc., San Diego, CA, US
Prosecution history
- 29 Jan 2026 — ASSIGNED TO EXAMINER
- 14 Sept 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Sept 2021 — SOU EXTENSION 3 GRANTED
- 19 May 2021 — SOU EXTENSION 3 FILED
- 25 Aug 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Aug 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Aug 2021 — NOTICE OF REVIVAL - E-MAILED
- 24 Aug 2021 — PETITION GRANTED - RESPONSE RECEIVED
- 22 Jul 2021 — TEAS RESPONSE TO PETITION DEFICIENCY RECEIVED
- 30 Jun 2020 — PETITION INQUIRY LETTER ISSUED
- 29 Jun 2021 — ASSIGNED TO PETITION STAFF
- 18 Jun 2021 — TEAS PETITION TO DIRECTOR RECEIVED
- 28 May 2021 — EXAMINER'S AMENDMENT ENTERED
- 27 May 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 May 2021 — EXAMINERS AMENDMENT E-MAILED